GUANGZHOU, China, March 31 China MedicineCorporation (OTC Bulletin Board: CHME; "China Medicine" or "the Company"), aleading distributor and developer of prescription and over-the-counterpharmaceuticals, traditional Chinese medicines (TCM), nutritional and dietarysupplements, medical devices, and medical formulations in the PRC, todayannounced that the Company will present at the upcoming Brean Murray Carret &Co. Mainland China Investor Tour of China on Thursday April 3, 2008 at MarcoPolo Hotel in Shenzhen, China.
Mr. Yang Senshan, China Medicine's Chairman and CEO, will present theoverview of the Company's main business, product lines, facilities,competitive strengths, and growth strategies at 9:45 am local time.
For more information about the conference, please visithttp://www.breanmurraycarret.com .
About China Medicine Corporation
China Medicine Corporation is a leading pharmaceutical company whichdiscovers and develops medical formulations and distributes over 2,200pharmaceutical products in China including prescription and over-the-counter("OTC") drugs, traditional Chinese medicine products, herbs and dietarysupplements. The Company distributes the products to wholesale distributors in28 provinces, more than 300 hospitals, 500 medicine companies, and 1,788 drugstores throughout China. The Company actively develops a number of proprietaryproducts for many uses including oncology, high blood pressure and the removalof toxins from food and animal feeds. For more information visit the Company'swebsite at http://www.chinamedicinecorp.com .
This press release contains forward-looking statements concerning theCompany's business and products. The Company's actual results may differmaterially depending on a number of risk factors including, but not limited to,the following: general economic and business conditions, obtaining regulatoryapproval for new products, the expected contribution of higher margin products,government support for rural health care, competition from existing and newcompetitors, changes in technology, and various other factors beyond itscontrol. All forward-looking statements are expressly qualified in theirentirety by this Cautionary Statement and the risk factors detailed in theCompany's reports filed with the Securities and Exchange Commission. ChinaMedicine Corporation undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of thisrelease.For more information, please contact: CCG Elite Investor Relations Inc. Mr. Crocker Coulson, President Tel: +1-646-213-1915 (New York) Email: [email protected]
China Medicine Corp Ms. Huizhen Yu, CFO Tel: +86-20-8739-1718 Email: [email protected]
SOURCE China Medicine Corporation